San Francisco Set To Ban Sales Of E-Cigarettes 26/06/2019 Editorial team By Laura Klivans, KQED / California Healthline June 25, 2019 San Francisco’s Board of Supervisors is slated to vote Tuesday to ban the sale and distribution of e-cigarettes in the city. The city is the corporate home of Juul Labs, the biggest producer of e-cigarettes in the country. The ordinances would make the sale of e-cigarettes illegal in […] Continue reading -> Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries 24/06/2019 Editorial team [By Reuters] NEW YORK (Reuters) – Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it[s] Medicare program on lower prices in other countries would face legal challenges if adopted. U.S. President Donald Trump said last year that one […] Continue reading -> Public Health-Driven R&D Focus Of Draft HRC Resolution On Access To Medicines & Vaccines 24/06/2019 David Branigan A United Nations Human Rights Council (HRC) draft resolution on access to medicines and vaccines calls for making public health needs more central to the research and development (R&D) of new health products, and for the new products to be priced to ensure access. Image Credits: United Nations. Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries 24/06/2019 Editorial team [By Reuters] NEW YORK (Reuters) – Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it[s] Medicare program on lower prices in other countries would face legal challenges if adopted. U.S. President Donald Trump said last year that one […] Continue reading -> Public Health-Driven R&D Focus Of Draft HRC Resolution On Access To Medicines & Vaccines 24/06/2019 David Branigan A United Nations Human Rights Council (HRC) draft resolution on access to medicines and vaccines calls for making public health needs more central to the research and development (R&D) of new health products, and for the new products to be priced to ensure access. Image Credits: United Nations. Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Public Health-Driven R&D Focus Of Draft HRC Resolution On Access To Medicines & Vaccines 24/06/2019 David Branigan A United Nations Human Rights Council (HRC) draft resolution on access to medicines and vaccines calls for making public health needs more central to the research and development (R&D) of new health products, and for the new products to be priced to ensure access. Image Credits: United Nations. Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Knowledge Portal On Innovation And Access To Medicines 14/06/2019 Editorial team Click here or on the image below to be redirected to the Knowledge Portal. Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As World Celebrates “No Tobacco Day,” Big Tobacco Seeks Rebrand To “No Smoking Day” 31/05/2019 David Branigan Amid calls by the World Health Organization to reduce tobacco use and improve lung health on this year’s “World No Tobacco Day,” tobacco industry giant Philip Morris has pushed back, calling on its longtime adversaries in the public health community to group instead around a “World No Smoking Day.” Image Credits: WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Assembly Approves Milestone Resolution On Price Transparency 28/05/2019 Elaine Ruth Fletcher The World Health Assembly today approved a milestone resolution to support greater public disclosure of prices for medicines and other health products – capping a nail-biting series of negotiations that continued until the very moment the measure came to the floor. Image Credits: Giulia Grillo, WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Posts navigation Older postsNewer posts